Back to results
US 2011/0212124 A1Published application
Vaccine Composition
OwnerDominique BOUTRIAU, Carine Capiau +3inventors
InventorsDominique BOUTRIAU, Carine Capiau, Pierre Michel Desmons, Dominique Lemoine, Jan Poolman
Life of this patent
Estimating the term…
Abstract
The present invention relates to new, advantageous DTP-based combination vaccine formulations, and concomitantly administered combination vaccine kits. Methods of administration of these vaccines and kits are also provided.
Claims19
A method of immunizing a human host against disease using an immunogenic composition in a first container comprising:
- (a) acellular pertussis components comprising pertussis toxoid and FHA,
- (b) tetanus toxoid (TT),
- (c) diphtheria toxoid (DT),
- (d) Hepatitis B surface antigen adsorbed onto aluminium phosphate, and
- (e) Inactivated polio virus,
- and an immunogenic composition in a second container comprising:
- (2a) one or more conjugates of a carrier protein and a capsular polysaccharide or oligosaccharide from Streptococcus pneumoniae,
- which method comprises
- administering an immunoprotective dose of the immunogenic composition of the first container to the host at a first site, administering an immunoprotective dose of the immunogenic composition of the second container to the host at a second site, wherein the first and second sites are drained by different lymph nodes.
6 more elements
Dependencies are inferred from the claim text.